Skip to content

Clinical trials

Phase 2 Ocular Hypertension trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ocular Hypertension Phase: Phase 2 Country / region: United States Clear all

87 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20052
20063
20077
20084
20098
20105
20116
20125
20138
20147
20153
20162
20173
20181
20192
20202
20214
20222
20233
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed83
Active, not recruiting1
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alcon Research12
Aerie Pharmaceuticals11
Mati Therapeutics Inc.9
Allergan8
Santen Inc.6
Qlaris Bio, Inc.5
ForSight Vision5, Inc.4
Amakem, NV2
Bausch & Lomb Incorporated2
Glaukos Corporation2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ocular Hypertension87
Glaucoma, Open-Angle63
Glaucoma44
Eye Diseases3
Hypertension3
Sturge-Weber Syndrome2
Exfoliation Syndrome1
Hydrophthalmos1

Trials

Showing 1 to 25 of 87. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.